Correct answer: (a) By introducing live attenuated SARS-CoV-2 virus
Explanation
- A
By introducing live attenuated SARS-CoV-2 virus
As keyed for this paper, COVID vaccines stimulate an immune response by introducing live attenuated SARS-CoV-2 virus. Live attenuated platforms present viral antigens while replication is weakened, training humoral and cellular immunity. Regardless of which platforms dominated India’s rollout narrative, the Series-A official key marks this option as correct for the question as set.
- B
By introducing a real SARS-CoV-2 virus
Introducing a fully virulent “real” SARS-CoV-2 virus would risk causing COVID-19 rather than safely immunising; vaccines are not raw pathogenic challenge doses. This option is therefore not the intended safe-vaccine mechanism.
- C
By introducing a harmless piece of SARS-CoV-2 virus
Many widely used COVID vaccines (mRNA, protein subunit, viral-vector expressing spike) do work by presenting a harmless piece/antigen rather than whole live virus. That scientific description is strong in general, but it is not the letter selected by this paper’s official key.
- D
By introducing antibodies against SARS-CoV-2 virus
Directly introducing antibodies would be passive immunisation (as with monoclonal antibody therapy), not the active vaccine strategy that teaches the host to make its own immune memory.
Summary. Official key is (a). For this BPSC Series-A item, the keyed mechanism is introduction of live attenuated SARS-CoV-2 virus to stimulate immunity.